Axsome Therapeutics (AXSM) Interest & Investment Income: 2022-2025
Historic Interest & Investment Income for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to -$1.1 million.
- Axsome Therapeutics' Interest & Investment Income rose 43.38% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year decrease of 50.07%. This contributed to the annual value of -$6.6 million for FY2024, which is 1.80% down from last year.
- As of Q3 2025, Axsome Therapeutics' Interest & Investment Income stood at -$1.1 million, which was up 38.93% from -$1.8 million recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Interest & Investment Income registered a high of -$702,000 during Q4 2023, and its lowest value of -$2.7 million during Q2 2023.
- Its 3-year average for Interest & Investment Income is -$1.7 million, with a median of -$1.8 million in 2025.
- Per our database at Business Quant, Axsome Therapeutics' Interest & Investment Income surged by 68.60% in 2023 and then tumbled by 214.81% in 2024.
- Axsome Therapeutics' Interest & Investment Income (Quarterly) stood at -$1.3 million in 2022, then spiked by 46.94% to -$702,000 in 2023, then crashed by 214.81% to -$2.2 million in 2024, then spiked by 43.38% to -$1.1 million in 2025.
- Its Interest & Investment Income stands at -$1.1 million for Q3 2025, versus -$1.8 million for Q2 2025 and -$2.4 million for Q1 2025.